OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience

被引：7

作者：

Vernieri, Fabrizio ^{[1
]}

Paolucci, Matteo ^{[1
]}

Altamura, Claudia ^{[1
]}

Pasqualetti, Patrizio ^{[2
]}

Mastrangelo, Vincenzo ^{[3
]}

Pierangeli, Giulia ^{[3
]}

Cevoli, Sabina ^{[3
]}

D'Amico, Domenico ^{[4
]}

Grazzi, Licia ^{[4
]}

机构：

[1] Policlin Univ Campus Biomed Roma, UOS Cefalee & Neurosonol, Via Alvaro Portillo 200, I-00128 Rome, Italy

[2] Fdn Fatebenefratelli Ric & Formaz Sanitaria & Soc, Serv Stat Med, Rome, Italy

[3] Univ Bologna, IRCCS Ist Sci Neurol Bologna, DIBINEM, Alma Mater Studiorum, Bologna, Italy

[4] Ist Neurol Carlo Besta, Milan, Italy

来源：

NEUROLOGICAL SCIENCES | 2018年 / 39卷

关键词：

PLACEBO-CONTROLLED PHASE; DOUBLE-BLIND; TRIAL;

D O I：

10.1007/s10072-018-3393-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：S171 / S172

页数：2

共 3 条

[1]

Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676

[2] Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment [J].

Bigal, Marcelo E. ;

Serrano, Daniel ;

Reed, Michael ;

Lipton, Richard B. .

NEUROLOGY, 2008, 71 (08) :559-566

[3] OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial [J].

Diener, H. C. ;

Dodick, D. W. ;

Aurora, S. K. ;

Turkel, C. C. ;

DeGryse, R. E. ;

Lipton, R. B. ;

Silberstein, S. D. ;

Brin, M. F. .

CEPHALALGIA, 2010, 30 (07) :804-814

← 1 →